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Species specific anaesthetics for 
fish anaesthesia and euthanasia
Gareth D. Readman1, Stewart F. Owen2, Toby G. Knowles3 & Joanna C. Murrell3
There is a need to ensure that the care and welfare for fish maintained in the laboratory are to the 
highest standards. This extends to the use of anaesthetics for both scientific study, humane killing and 
euthanasia at end of life. An anaesthetic should not induce negative behaviours and fish should not 
seek to avoid the anaesthetic. Surprisingly little information is available to facilitate a humane choice 
of anaesthetic agent for fish despite over 100 years of use and the millions of fish currently held in 
thousands of laboratories worldwide. Using a chemotaxic choice chamber we found different species 
specific behavioural responses among four closely related fish species commonly held in the laboratory, 
exposed to three widely used anaesthetic agents. As previously found for zebrafish (Danio rerio), the 
use of MS-222 and benzocaine also appears to induce avoidance behaviours in medaka (Oryzias latipes); 
but etomidate could provide an alternative choice. Carp (Cyprinus carpio), although closely related to 
zebrafish showed avoidance behaviours to etomidate, but not benzocaine or MS-222; and rainbow 
trout (Oncorhynchus mykiss) showed no avoidance to the three agents tested. We were unable to 
ascertain avoidance responses in fathead minnows (Pimephales promelas) and suggest different test 
paradigms are required for that species.
Summaries in the journal Nature1, 2 and also the report from the second Newcastle meeting on laboratory animal 
euthanasia3 have highlighted that the humane use of anaesthesia for fish is far more complicated than previously 
thought. The publication of two studies using different behavioural test paradigms: a chemotaxic chamber4 and 
conditioned place avoidance5 have demonstrated the avoidance of the Zebrafish (Danio rerio) to the commonly 
used anaesthetic Tricaine methanosulphate (MS 222). The European directive (2010/63 EU) article 146, which 
covers the protection of animals used for scientific purposes, specifically states that any severe procedure should 
not be conducted without anaesthetic and that for other procedures the use of anaesthesia should be based on a 
utilitarian benefit commensurable with the aims of the procedure. For mammals, standard practice uses species 
specific choice of anaesthetic agent. This is to facilitate effective anaesthesia and to reduce negative behavioural 
responses to the anaesthetic agent in the early stages of induction. As different responses to anaesthetics are 
apparent even among relatively closely related mammalian species (e.g. mice and rats)7, it seems logical to ask if 
there are similar considerations for fish, viz. are there species specific requirements for anaesthetic agents in fish?
Assessment of the practical aspects of using different anaesthetics, for different fish species have been reviewed 
in several papers8–13. These reviews generally focus on ease of delivery, rapid onset and stability, and not the 
potential welfare implications associated with induction. To date, it appears that the welfare implication of each 
potential anaesthetic has not been considered on a species specific basis for fish. In fact it seems a ‘one size fits 
all’ approach is advocated by many9. It is clear that regardless of the time it takes to anaesthetise a fish, the first 
fundamental question should be ‘does it produce avoidance behaviour?’ Beyond that question the next should be 
‘does it act as an anaesthetic?’ It is difficult to answer the second question conclusively without physiological and 
bioelectric evidence and we do not attempt to do so in this paper. The first question however is relatively simple. 
Indeed there are several approaches with which to answer this question4, 5; and the answer for one species (zebraf-
ish) already appears to be that many commonly used anaesthetics provoke negative behavioural responses4, and 
most importantly that zebrafish appear to retain some memory of the event5. Therefore, there is clear evidence 
that humane choices for that species can now be made based on behavioural responses indicative of avoidance 
behaviour4.
There are likely hundreds of diverse species of fish used in scientific experiments globally. However, the 
range of species used in large numbers is somewhat more restricted. For example, commonly recommended 
1School of Biological and Marine sciences, University of Plymouth, Plymouth, PL4 8AA, United Kingdom. 
2AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TF, United Kingdom. 3School of Veterinary Science, 
University of Bristol, Langford House, Langford, Bristol, BS40 5DU, United Kingdom. Correspondence and requests 
for materials should be addressed to G.D.R. (email: gareth.readman@plymouth.ac.uk)
Received: 24 January 2017
Accepted: 20 June 2017
Published online: 2 August 2017
OPEN
www.nature.com/scientificreports/
2Scientific REPORts | 7: 7102 | DOI:10.1038/s41598-017-06917-2
species in Organisation for Economic Cooperation and Development (OECD) and Environmental Protection 
Agency (EPA) guidelines for use in regulatory testing represent some of the most commonly used species after 
zebrafish; and several of these species crossover into aquaculture research (carp (Cyprinus carpio), rainbow trout 
(Oncorhynchus mykiss), salmon (Salmo salar)). Here we chose four commonly used species; carp, fathead min-
nows (Pimephales promelas), medaka (Oryzias latipes) and rainbow trout. These species represent a range of those 
used in significant numbers in research, and their responses to the two most commonly used anaesthetics MS 222 
and benzocaine were assessed. We also examined their response to etomidate which was previously shown not to 
provoke avoidance behaviours in Zebrafish4.
Results
The parameter estimates produced by MLwiN (Table 1) show the average time spent in the control lane compared 
with the time spent in the exposure lane and the statistical significance of any difference. For example, if we look 
at the analysis for Ethanol and choose carp as our species then the model shows that the average time spent in the 
exposure lane was 11.6 seconds less than that of the control value of 81.9 seconds, and that there was no significant 
difference in the time spent in either lane.
Control exposures. No preference for the amount of time spent in either lane (right versus left) was demon-
strated in the absence of test compounds for any of the species tested, demonstrating no environmental bias in 
the system.
Positive control. Hydrochloric acid (HCl resulting in approximately pH 3) was used as a positive control to 
assess the functionality of the system and to provide a model of altered behavioural response. Of the species tested 
carp, medaka and rainbow trout all showed significant aversion to HCl (P < 0.001), since they spent significantly 
less time in the exposure versus treated lane. Fathead minnows showed no significant difference in time spent in 
either exposure or control lane (Table 1).
Control (No compound) Time in clean lane (secs) Treatment lane difference (secs)
Carp 76.155 (7.421) −9.890 (8.569)
Fathead Minnow 80.343 (14.308) 21.625 (16.522)
Medaka 96.190 (12.007) −2.760 (13.865)
Rainbow trout 67.345 (9.065) −8.820 (10.467)
HCl Time in clean lane (secs) Treatment lane difference (secs)
Carp 131.938 (7.952) −97.695 (9.182)***
Fathead Minnow 83.168 (12.354) −5.155 (14.265)
Medaka 101.130 (13.044 −61.290 (15.062)***
Rainbow trout 118.557 (6.088) −64.555 (7.030)***
Ethanol Time in clean lane (secs) Treatment lane difference (secs)
Carp 81.942 (19.038) −11.605 (11.481)
Fathead Minnow 74.652 (17.046) −10.515 (19.683)
Medaka 79.223 (5.473) −10.635 (6.319)
Rainbow trout 77.972 (7.689) 8.315 (8.878)
Benzocaine Time in clean lane (secs) Treatment lane difference (secs)
Carp 79.005 (13.831 14.530 (15.971)
Fathead Minnow 63.880 (17.480) 10.200 (20.184)
Medaka 101.638 (13.772) −24.235 (8.305)**
Rainbow trout 99.680 (11.825) −16.730 (13.654)
Etomidate Time in clean lane (secs) Treatment lane difference (secs)
Carp 82.618 (7.236) −21.595 (8.355)**
Fathead Minnow 66.133 (16.463) 33.185 (19.010)
Medaka 68.933 (5.970) 4.625 (6.894)
Rainbow trout 54.585 (12.454) 18.140 (14.381)
MS222 Time in clean lane (secs) Treatment lane difference (secs)
Carp 68.850 (11.199) 9.280 (12.932)
Fathead Minnow 52.700 (13.027) 47.460 (15.042)***
Medaka 88.027 (5.710) −38.645 (6.594)***
Rainbow trout 95.652 (9.377) −10.515 (10.828)
Table 1. Summary of MLwiN estimates (±SEM) of the effects for each of the anaesthetic agents in dilution 
water versus exposure for the response variable Time. Statistical significance is denoted by *P < 0.05, 
**P < 0.01, ***P < 0.001.
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Solvent control. None of the species tested showed difference in the time spent in exposure versus control 
lanes (Table 1), suggesting that ethanol was not aversive at the level used in this study (approx. 0.033% of final 
exposure). This lack of preference indicates that the use of ethanol at this concentration as a carrier solvent does 
not create an aversive response in itself.
Benzocaine. Of the species tested only medaka showed a significant avoidance (P < 0.01) based on the time 
spent in exposure versus control lanes. Fathead minnow, carp and rainbow trout showed no significant difference 
in time spent in either lane (Table 1).
Etomidate. Carp were the only species to show significant avoidance (P < 0.01) spending less time spent in 
exposure versus control lanes, fathead minnows, medaka and rainbow trout showed no significant difference 
between either lane (Table 1).
MS 222. Medaka showed a significant difference in the time spent in exposure versus control lanes (P < 0.001) 
showing avoidance of MS 222. Carp and rainbow trout showed no significant difference in time spent in either 
lane (Table 1), while fathead minnows showed a significant preference for the lane containing the MS222 versus 
the control lane (P < 0.01).
pH measurements. At no point during the exposure of any anaesthetic compounds did the pH values in the 
experimental or control lane differ by more than one pH unit, across each experimental group (n = 20).
Although routine practice is to buffer MS222 due to the reduction in pH caused by its addition, within this 
study the pH was not buffered due to the inherent capacity of the holding water (potable mains water treated to 
achieve OECD standards) resultant mean/min/max values for pH during exposure of MS222 to the four different 
species was as follows: Carp = 6.90/6.58/7.40, fathead minnow = 7.14/6.88/7.39, medaka = 7.10/6.93/7.35 and 
rainbow trout = 7.10/6.96/7.30.
Discussion
A chemotoxic preference test with quantitative analysis (time) was used to assess the difference in a specific 
behaviour of four fish species to three commonly used anaesthetics. This method was used previously4 to examine 
the behavioural differences of a single species, zebrafish (Danio rerio), and define to the response to nine anaes-
thetics previously used for fish. There has been a little confusion and the work accidentally miss-cited6; for clarity 
the exposure concentrations tested in Readman et al.4 was to half the dose required for anaesthesia (Table 2), 
and metomidate [CAS 5377-20-8] was not tested for aversion and is different to etomidate [CAS 33125-97-2]4. 
However both substances are GABA modulating agents and a different mode of action to the sodium-channel 
blockers such as MS222. However, as with all pharmaceutical agents, the uptake, pharmacokinetics, receptor 
binding and activities will be different for each compound, and likely each species and will need to be compared 
head-to-head to assess any potential differences. The recommendation from our previous work for adult zebrafish 
was to suggest etomidate was the best option for routine anaesthesia4. As with all anaesthesia protocols attention 
should be paid not only to the appropriate species-specific compound used to achieve anaesthesia, but also to 
the aim of the protocol. Careful choice of the compound might allow synergistic or potential analgesic effects of 
the anaesthetic used post-operatively. Best practice could include a cost benefit analysis of the potential suffering 
caused at any point before, during or after the procedure.
No difference was detected in the time spent in the exposure versus control lane during clean water exposure, 
showing no environmental bias within the system or for the solvent control, suggesting that any effects were 
driven by avoidance of the anaesthetic compound and not the environment or the solvent carrier. During the 
study pH within the control and exposure lanes did not differ by more than one unit and it was not considered 
necessary to buffer all of anaesthetic stocks due to the nature of the compounds and high dilution factor as well 
as the inherent buffering capacity of the dilution water. PH changes however, do effect the chemistry of the water, 
and critically the PCO2 is dependent on pH. Adding anaesthetic compounds to aquarium water may have effects 
on several physiological parameters such as pH, pCO2, osmolarity. Changes in these parameters may also induce 
avoidance or aversive responses. Whilst carbon dioxide is itself often considered an anaesthetic, the pH differ-
ences at approximately neutral values used in this study will drive relatively small changes typical of the pragmatic 
use of the agents and likely not exceed differences experienced in the wild.
A highly significant statistical difference was observed for carp, medaka and rainbow trout when exposed to 
HCl as a positive control. This combined with a lack of environmental bias in the clean water exposures, suggests 
that these fish were suitable test species for this behavioural model. The fathead minnow however, showed no 
response to HCl as a positive control. Indeed 2 (of 20) fish spent 100% of their time in the exposed lane, suggest-
ing either an inability to detect HCl or that the cost benefit associated with moving was considered by the fish to 
be greater than the effects of the HCl.
The fathead minnow has an established history of use within behavioural testing, use as a species for pref-
erence and avoidance testing for aquatic contaminants14; avoidance of zinc15, and behavioural avoidance of 
fluoranthene16. However, results presented here are difficult to quantify as the positive control using HCl failed to 
demonstrate an effect. Additionally a statistically significant preference for MS222, was seen with fathead minnow 
choosing to spend a greater percentage of the experimental time in the exposure lane. In fact six (of 20) fathead 
minnow chose never to leave the exposure lane. It is not known what elicited this response, or in fact if the 
response was behavioural or possibly due to greater induction in the anaesthetic than anticipated. We purpose-
fully chose half of the typical induction dose and a relatively short exposure time to minimise potential anaesthe-
sia induction in the test fish, whilst attempting to optimise the relevance to practicable anaesthesia practice. Based 
on the lack of positive control, the results for fathead minnow are therefore inconclusive and we would suggest the 
use of an alternative positive control or even test paradigm for use with this species.
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Importantly, of the three anaesthetics tested no single anaesthetic elicited the same behavioural responses 
in all four fish species. Benzocaine elicited a significant avoidance response in medaka, but in none of the other 
species tested. Etomidate elicited a significant avoidance response in carp, but again in none of the other species 
tested, MS222 also elicited a significant avoidance response in medaka but in none of the other species tested.
Benzocaine and MS222 have both been used historically as an anaesthetic for all of the species tested suggest-
ing they are an effective anaesthetic. It is proposed that anaesthesia is via a specific mode of action, in the case 
of benzocaine and MS222 reduced initiation and propagation of action potentials by blocking voltage-sensitive 
sodium channels12, 17. If blocking sodium channels does not induce avoidance in all the species tested, then this 
behavioural reaction must likely be caused by some other pathway such as some other physical properties of 
the anaesthetic and not by the induction of anaesthesia. Both benzocaine and MS222 have previously elicited 
different stress responses when exposed to three different species, Atlantic cod (Gadus morhua), Atlantic halibut 
(Hippoglossus hippoglossus) and Atlantic salmon (Salmo salar), despite likely having the same mode of action18. 
This would support the contention that avoidance is likely due to some aspect of the physical properties of the 
compounds; possibly acting as an irritant or aversive to taste/smell receptors.
According to the annual statistics for the use of animals in scientific studies within the UK as released by 
the Home office (https://www.gov.uk/government/statistics), for the cumulative data available between 2001 and 
2013 the UK used a total of 4,622,397 fish in scientific procedures of which 38.3% were exposed to anaesthesia at 
some part of the study (includes recovery and non-recovery procedures, data on anaesthesia use stopped being 
collected in 2014). These figures only represent those fish used for scientific procedures, and not fish used in 
work deemed to be sub threshold i.e. studies not deemed to have the potential to cause pain, suffering, distress or 
lasting harm, or animals held for husbandry and breeding, or the production of tissues. In practice, we suggest 
many laboratory fish will experience anaesthesia, but for most fish the first and only exposure to an anaesthetic 
agent would be during humane killing and euthanasia. Euthanasia is often defined as “a good death” and therefore 
exposure to any agent used should not elicit avoidance behaviours in order to meet definitions of humane19, there-
fore investigations within this study focussed on initial exposure and not potential behavioural changes caused by 
repeat exposures. The UK data report that 31.5% of all fish in the 2001 to 2013 period actually underwent recov-
ery, so some may well have gone on to experience anaesthesia for a second time or more, particularly if humanely 
killed or euthanised using anaesthesia as the first step. This is important if we are to understand the findings that 
zebrafish can retain an apparent memory of and avoid the place in which they were anaesthetised5. For medaka 
and carp based on the evidence collected here we recommend a humane approach to anaesthesia and first step of 
euthanasia would be to consider a species specific anaesthetic: avoiding benzocaine in medaka and etomidate for 
carp. For rainbow trout it appears that all three anaesthetics tested were appropriate.
Within this study three of the species tested were cyprinids (carp, fathead minnow and medaka) and differ-
ences were seen between these closely related species, as well as between the fourth species which was a salmonid. 
In our previous work we found nine anaesthetics induced avoidance for a fourth cyprinid species (zebrafish) and 
results presented for that species are further supported independently5. Reportable differences between three 
closely related cyprinid species provide evidence for the requirement for species specific anaesthesia to be empir-
ically reviewed by species. The need for individual empirical review is further strengthened by the different stress 
responses to anaesthetics with the same mode of action within a single fish species11.
The fact that MS222 did not elicit avoidance in rainbow trout is contrary to several other publications20–22 and 
also what has been seen anecdotally by the authors. It is possible however, that the lower dose rate used within this 
study, 50% of the effective dose seen within the literature (Table 2) was not high enough to elicit any behaviours 
Species Test substance
Effective 
published dose*
Test 
concentration Reference Supplier
Stock 
base
All
Baseline control (no exposure) N/A N/A N/A N/A N/A
Hydrochloric acid (+ve control) pH 3.0 N/A N/A N/A Sigma - Aldrich N/A
Ethanol 99.8% (solvent control) 1 ml/L 1 ml/L N/A Sigma - Aldrich N/A
Carp
Benzocaine 100 mg/L 50 mg/L 9, 10, 12, 22, 24 Sigma - Aldrich Ethanol
Etomidate 1 mg/L 0.5 mg/L 9, 10, 12, 25 Ark Pharm Inc Ethanol
MS222 100 mg/L 50 mg/L 9, 10, 12, 26, 27 Sigma - Aldrich Water
Fathead Minnow
Benzocaine 100 mg/L 50 mg/L 9, 10, 12, 22, 24 Sigma - Aldrich Ethanol
Etomidate 4 mg/L 2 mg/L 10, 12, 28 Ark Pharm Inc Ethanol
MS222 75 mg/L 37.5 mg/L 10, 12, 28 Sigma - Aldrich Water
Medaka
Benzocaine 100 mg/L 50 mg/L 9, 10, 12, 22 Sigma - Aldrich Ethanol
Etomidate 2 mg/L 1 mg/L 9, 10, 12, 22 Ark Pharm Inc Ethanol
MS222 100 mg/L 50 mg/L 10, 12, 29 Sigma - Aldrich Water
Rainbow Trout
Benzocaine 100 mg/L 50 mg/L 9, 10, 12, 22, 24 Sigma - Aldrich Ethanol
Etomidate 2 mg/L 1 mg/L 9, 10, 12, 25 Ark Pharm Inc Ethanol
MS222 90 mg/L 45 mg/L 9, 10, 12 Sigma - Aldrich Water
Table 2. Test substance effective dosage and supplier details. *Effective dose = Dose at which Stage 5 
anaesthesia is achieved. Where the referenced articles cite multiple alternative concentrations, the median was 
chosen. AstraZeneca do not endorse or recommend any companies listed, other suppliers were available.
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previously seen in these other studies. It may also be the case that higher concentrations of the other agents could 
also present a relative change in behaviour.
Conclusions
Within the framework of Directive 2010/63 EU6 there is an acceptance that any work undertaken will incorporate 
the objectives of the 3 R’s (Reduction, Replacement, Refinement). This study presents the evidence for avoidance 
to commonly used anaesthetics based on one behavioural model, and a limited number of species and strains 
thereof. Further work is needed within this field to understand behavioural response to anaesthetics within a 
greater number of species and to identify any strain differences within these species. The use of other behavioural 
models is also key, in order to fully account for behaviours not easily detected by one system and also to under-
stand the potential lack of suitability of different test species to one particular behavioural paradigm. It is there-
fore paramount that work undertaken with fish species that involves any element of anaesthesia must be reviewed 
to ensure that best practice is used commensurable with the aims of the study and that this is done on a species 
by species basis. Consideration must be given to the morphology and behaviour of individual species as well as 
the specific aims of the study and should be adopted as best practice for fish anaesthesia. It may also be the case 
that higher concentrations of the agents could also present a relative change in behaviour, however regardless of 
the mechanism that induces avoidance, a humane anaesthetic protocol should not elicit an avoidance or aversion 
response. We also note that the arbitrary restrictions on anaesthetic agents of some countries could make this 
difficult to implement and so call for international co-operation in establishing best practice.
From the work presented here and in previous submissions4; Medaka and zebrafish appear not to avoid etomi-
date, but avoid benzocaine and MS222. Carp appear not to avoid benzocaine or MS222, but do avoid etomidate. 
Rainbow trout show no difference in their response to etomidate, benzocaine or MS222. We are unable to draw 
any conclusions for fathead minnows under this test paradigm.
Methods
Ethics Statement. All the experimental in vivo protocols and procedures involving fish were performed 
in accordance with the United Kingdom’s Animals (Scientific Procedures) Act. The in vivo studies were under-
taken at Brixham Environmental Laboratory, AstraZeneca (United Kingdom) under Project and Personnel 
Licences granted by the Home Office. All in vivo experimental protocols were also approved by the local Ethical 
Committee at Brixham Environmental Lab in accordance with AstraZeneca’s local and global ethical policies. 
This work is reported in compliance with the ARRIVE guidelines and details are collated in the ARRIVE supple-
mentary information S1.
Test species and procedure. Differences in behavioural response to three commonly used anaesthetics 
were investigated in the following fish species: carp, fathead minnows, medaka and rainbow trout. Twenty ani-
mals where used per treatment group (control, positive control, solvent control, benzocaine, MS222 and etomi-
date) and the study used 480 fish in total (4 species × 20 fish × 6 treatments). Replicate numbers were optimised 
for the study design from our previous experience with zebrafish4.
Application of a chemotaxic chamber to study behavioural aversion to anaesthetics has previously been 
described in detail4, and is outlined briefly here. Individual fish of each species were transferred from stock tanks 
into the flow by means of a beaker containing a small volume of water (avoiding air exposure). After the transfer, 
fish were allowed to acclimate for 150 seconds and subsequently a continuous dose of the test compound at a pre-
determined concentration was introduced via an open port into the top of one of the water inlets that provided 
the incoming flow for a period of 150 seconds. The inlet was submerged to allow the greatest mixing with the 
minimum surface disturbance in order to preserve the laminar flow. The side receiving the test compound was 
alternated for each experimental run using a pre-determined order. The injection of test compound at this point 
allowed for mixing into the incoming flow, with additional time for mixing in the chamber prior to the baffle. The 
pH was measured in the mixing chamber in the main body of water to ensure an accurate reading and the final 
reading was recorded for each exposure in both the clean and exposure lanes. The horizontal gradient created 
by the laminar flow within the tank allowed the untreated lane to remain uncontaminated, so creating two lanes 
between which the fish could move freely. Following each experiment with one fish, the system was manually 
flushed with clean water to remove any test compound residues. The location and activity of the fish with access 
to both the treated and untreated lane, were recorded via video camera for the whole experimental period. The 
video camera was positioned directly above the tank, ensuring that the camera did not create any shadowing on 
the water that could influence lane choice by the test fish. Offline analysis of the video recordings was carried out 
using VideoTrack analysis software (Version 2.5.0.25, ViewPoint, Lyon, France), and analysed over the 150 second 
exposure period; the results for each test substance were analysed separately. The data output from VideoTrack 
was subsequently formatted in Excel (Microsoft office, 2007) for statistical analysis using MLwiN23 (available at 
http://www.bristol.ac.uk/cmm/software/mlwin/). The data were tested against a pre-specified, multilevel model. 
A multilevel approach was used as it allowed the data structure of the repeated measurements made on each fish 
(i.e. a measurement for each lane) to be taken into account. A general linear model within the multilevel model 
then included a term for the effect of treatment lane compared with control lane and also a term for the right hand 
side of the equipment compared with the left hand side, to ensure that no intrinsic bias was present within the 
experimental setup. These terms in the model were then tested, using a Chi square statistic, against a change in log 
likelihood. From the control data, there was no evidence of a left/right flow chamber bias so only the parameter 
estimates of the effects of the anaesthetic treatments are presented here (Table 1).
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Test substance. Details of the anaesthetics examined in the experiment are listed in Table 2. Each was used at 
a concentration of 50% of the effective (Table 2), published dose required to produce anaesthesia. All anaesthetic 
stocks were prepared in accordance with standard practice12. To achieve the high stock concentration required 
for dosing, benzocaine was first solubilised in ethanol. It was not necessary to buffer any of the stocks due to the 
inherent pH values, this included MS 222. Although MS222 is capable of reducing the pH of dilution water, in this 
study due to the low dose rate and the inherent buffering capacity of the (OECD) dilution water the pH within the 
exposure lane never exceeded a difference of more than ±1.0 of that of the control. Effects of a reduction by this 
amount are deemed to have minimal effects on most fish species9.
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